The effect of intranasal midazolam on children sedatio
Phase 3
- Conditions
- Pediatrics Sedation.
- Registration Number
- IRCT20171009036661N3
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
age 2 to 12 years old
mild to moderate traumatic brain injury
no concomitant nasal trauma or nasal anatomic abnormality
Exclusion Criteria
1. Parental dissatisfaction
GCS=8
Unstable hemodynamic
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sedation Level. Timepoint: 15 minutes after intranasal method and 30 minutes after oral method. Method of measurement: Nialc Wilton Method.
- Secondary Outcome Measures
Name Time Method Parent's level of satisfaction from procedure. Timepoint: After completing procedure. Method of measurement: Questionnare.